We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Improved Control for Anti-Coagulation Therapy

By HospiMedica staff writers
Posted on 14 Apr 2008
A new communication device helps clinicians obtain an overview of a patient's coagulation monitoring test results, making confident decision-making easier and leading to more successful therapy.

The CoaguChek XS Connect device is a small, compact, and easy to use device used to download international normalized ratio (INR) results from a CoaguChek XS system to a computer for efficient interpretation and subsequent action. More...
The device provides customizable reports and trend graphs, which can be reviewed on the computer screen, stored, and printed out. Only minimum computer literacy is required, and no software needs to be installed; the device is simply plugged into a universal serial bus (USB) port, and is recognized by the computer. The USB port also provides the power for the battery-free device. Results from the memory of the CoaguChek XS instrument can be viewed with a spreadsheet program such as Microsoft Excel, stored, or sent by e-mail. Data transfer to other software applications allows healthcare professionals to collect and further process patient data in their own office's environment. The CoaguChek XS system and the Connect device are products of Roche (Basel, Switzerland).

"The new CoaguChek XS Connect device has been designed to make these tasks easy, fast and convenient,” said Patrick Wieghardt, of Roche Professional Diagnostics. "Only three steps are required to download test results from a CoaguChek XS meter to a computer. This means, reduced risk of incorrect result reporting, and an easy-to-review overview for patients and healthcare professionals within seconds.”

Oral anti-coagulation therapy is an important treatment for patients with specific medical conditions such as mechanical heart valves, atrial fibrillation, or thromboembolic venous diseases. Frequent monitoring to support drug-dosing adjustments and to stay within the therapeutic range has proved to be an essential element in the success of every therapy.


Related Links:
Roche

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.